Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (181-190 of 302) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|February 6, 2019
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancerMegan L Hutchcraft, Blair Smith, Eric M McLaughlin, et al.
Psycho-Oncology|October 19, 2018
Pilot randomized controlled trial of a symptom cluster intervention in advanced cancerSharla M Wells-Di Gregorio, Donald R Marks, Joseph DeCola, et al.
International Journal of Cancer|June 25, 2017
Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinomaKristin Bixel, Uksha Saini, Hemant Kumar Bid, et al.
Cancer|September 26, 2023
Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancersCourtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.
Gynecologic Oncology|January 30, 2013
Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage diseaseGeorgia A McCann, Christina E Boutsicaris, Megan M Preston, et al.
Gynecologic Oncology|August 2, 2014
Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?Floor J Backes, Caroline C Billingsley, Douglas D Martin, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Cancer|June 29, 2004
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group studyRobert A Burger, Kathleen M Darcy, Philip J DiSaia, et al.
Journal of Oncology Practice|January 4, 2017
Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian CancerJonathan R Foote, Micael Lopez-Acevedo, Adam H Buchanan, et al.
Gynecologic Oncology|October 8, 2013
Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality careMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Pageof 31

Showing results (181-190 of 302) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|February 6, 2019
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancerMegan L Hutchcraft, Blair Smith, Eric M McLaughlin, et al.
Psycho-Oncology|October 19, 2018
Pilot randomized controlled trial of a symptom cluster intervention in advanced cancerSharla M Wells-Di Gregorio, Donald R Marks, Joseph DeCola, et al.
International Journal of Cancer|June 25, 2017
Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinomaKristin Bixel, Uksha Saini, Hemant Kumar Bid, et al.
Cancer|September 26, 2023
Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancersCourtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.
Gynecologic Oncology|January 30, 2013
Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage diseaseGeorgia A McCann, Christina E Boutsicaris, Megan M Preston, et al.
Gynecologic Oncology|August 2, 2014
Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?Floor J Backes, Caroline C Billingsley, Douglas D Martin, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Cancer|June 29, 2004
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group studyRobert A Burger, Kathleen M Darcy, Philip J DiSaia, et al.
Journal of Oncology Practice|January 4, 2017
Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian CancerJonathan R Foote, Micael Lopez-Acevedo, Adam H Buchanan, et al.
Gynecologic Oncology|October 8, 2013
Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality careMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Pageof 31